View Older Stories View More Recent Stories

Aug 21, 2018 09:25AM Cytosorbents (CTSO) Secures Up to $3M Award in SBIR Phase IIB Funding by NIH/NHLBI to Accelerate U.S. Approval & Commercialization of HemoDefend Blood Transfusion Filter
Aug 21, 2018 09:06AM CytoSorbents Awarded up to $3M in SBIR Phase IIB Bridge Funding by NIH/NHLBI to Accelerate U.S. Approval and Commercialization of the HemoDefend™ Blood Transfusion Filter
Aug 2, 2018 04:15PM CytoSorbents Achieves Record Total Revenue and CytoSorb Sales in the Second Quarter 2018
Jul 31, 2018 07:08AM CytoSorbents Expands Distribution of CytoSorb® to a Total of 53 Countries Worldwide
Jul 26, 2018 07:00AM CytoSorbents to Report Q2 2018 Operating and Financial Results
Jul 9, 2018 08:00AM Aferetica and CytoSorbents Debut the PerLife™ System for Organ Preservation and Rehabilitation at the 27th International Congress of the Transplantation Society
Jun 26, 2018 07:08AM CytoSorbents Added to the Russell 2000 and Russell 3000 Indexes
Jun 12, 2018 07:08AM CytoSorbents Officially Opens New U.S. CytoSorb Manufacturing Facility
Jun 4, 2018 07:30AM CytoSorbents to Present at the Jefferies 2018 Global Healthcare Conference
May 21, 2018 09:26AM CytoSorbents to Present at the 19th Annual B. Riley FBR Investor Conference
May 14, 2018 07:16AM Cytosorbents (CTSO) Reports Addition of Bilirubin and Myoglobin Reduction to EU Approved Indications for Use
May 14, 2018 07:08AM CytoSorb® Adds Bilirubin and Myoglobin Reduction to European Union Approved Indications for Use
May 8, 2018 04:15PM CytoSorbents Reports Strong First Quarter 2018 Financial Results
May 2, 2018 07:00AM CytoSorbents to Report Q1 2018 Operating and Financial Results
Apr 24, 2018 07:08AM CytoSorbents Enrolls First Patient into Pivotal U.S. REFRESH 2-AKI Trial Using CytoSorb® During Complex Cardiac Surgery
Apr 9, 2018 01:57AM CytoSorbents to Meet With European Investors at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo and in Meetings in Frankfurt, Geneva and Zurich
Apr 4, 2018 06:55AM CytoSorbents Refinances Existing Debt with New $15 Million Debt Facility with Bridge Bank
Mar 28, 2018 09:17AM CytoSorbents Reports on the Successful 5th International CytoSorb Users Meeting and 38th ISICEM Critical Care Conference
Mar 12, 2018 07:00AM CytoSorbents to Present at the 38th Annual Cowen Healthcare Conference
Mar 8, 2018 04:15PM CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017
Mar 1, 2018 08:00AM CytoSorbents to Report Fiscal 2017 Operating and Financial Results
Feb 26, 2018 07:10AM CytoSorbents to Participate at the BTIG Healthcare Conference
Feb 15, 2018 06:55AM CytoSorbents Expands Its Partnership with Biocon to Launch CytoSorb® in Malaysia
Feb 6, 2018 07:08AM CytoSorbents to Present at the 20th Annual BIO CEO & Investor Conference
Feb 1, 2018 07:20AM New Study Demonstrates Improved Hemodynamic Stability After Heart Transplant Surgery using Intraoperative CytoSorb® Blood Purification
Jan 8, 2018 07:23AM Cytosorbents (CTSO) Pre-Announces Prelim. 4Q & FY17 Revenues Slightly Above Consensus; CEO Dr. Phillip Chan Release Shareholder Letter
Jan 8, 2018 07:15AM CytoSorbents Pre-Announces Preliminary Fourth Quarter and Full Year 2017 Results and Issues Stockholder Letter
Jan 3, 2018 07:05AM CytoSorbents To Provide Corporate Update at Biotech Showcase 2018
Dec 21, 2017 02:59PM Cytosorbents (CTSO) Announces FDA Approval of U.S. REFRESH 2 Pivotal Cardiac Surgery Trial IDE Application with Conditions
Dec 21, 2017 02:58PM CytoSorbents Achieves Key Milestone with FDA Approval of the U.S. REFRESH 2 Pivotal Cardiac Surgery Trial IDE Application
Dec 19, 2017 07:00AM CytoSorbents Receives $676,739 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program
Dec 11, 2017 08:10AM German Federal Ministry of Education and Research to Fund the CytoSorb® Endocarditis REMOVE Trial
Nov 29, 2017 07:00AM CytoSorbents to Present at the LD Micro Main Event Investor Conference
Nov 9, 2017 04:17PM CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017
Nov 9, 2017 07:15AM CytoSorbents Recognized on Deloitte's 2017 Technology Fast 500™ as One of the Fastest Growing Companies in North America
Nov 2, 2017 08:00AM CytoSorbents to Report Q3 2017 Operating and Financial Results
Nov 1, 2017 07:05AM CytoSorbents Awarded Approximately $1.0 Million in Phase II SBIR Funding to Optimize New Treatment Approaches for Severe Hyperkalemia
Oct 19, 2017 09:25AM CytoSorb® Usage During Valve Replacement Surgery for Infective Endocarditis Helps Stabilize Patients and May Improve Survival
Oct 10, 2017 07:15AM CytoSorbents to Present at the 2017 BIO Investor Forum
Sep 26, 2017 07:05AM CytoSorbents Introduces the CytoSorb Therapeutic ECMO™ Kit at the 2017 European Society of Intensive Care Medicine Congress
Sep 25, 2017 07:18AM Cytosorbents (CTSO) Says Key Clinical Study Shows Reversal of Refractory Septic Shock in Patients Treated with CytoSorb
Sep 25, 2017 07:15AM Key Clinical Study Showing Reversal of Refractory Septic Shock in Patients Treated with CytoSorb®
Sep 14, 2017 08:15AM World Sepsis Day 2017: CytoSorbents Sponsors the Sepsis Update 2017 Congress and Sepsis Heroes Ceremony
Sep 11, 2017 07:15AM Aferetica and CytoSorbents Partner to Enhance the Success of Solid Organ Transplantation
Sep 6, 2017 07:00AM CytoSorbents to Present at the 2017 Rodman & Renshaw Annual Global Investment Conference
Sep 5, 2017 08:05AM CytoSorbents Highlights Important Research Advances in Traumatic Brain Injury, Hemorrhagic Shock, and Severe Hyperkalemia at the Military Health System Research Symposium
Aug 14, 2017 07:22AM Cytosorbents (CTSO) Secures $719K Grant to Acutely Stabilize Severe Burn Patients
Aug 14, 2017 07:15AM CytoSorbents Awarded $719,000 Grant To Acutely Stabilize Severe Burn Patients
Aug 7, 2017 04:15PM CytoSorbents Reports Record Quarterly Total Revenue and Product Sales in the Second Quarter 2017
Aug 1, 2017 07:00AM CytoSorbents to Report Q2 2017 Operating and Financial Results
View More Recent Stories View Older Stories